PharmacyCodes



Furedan en es it fr

Categoria

Furedan Marchi, Furedan Analoghi

Furedan Marchi miscela

  • No information avaliable

    • Furedan Formula chimica

    C8H6N4O5

    Furedan RX link

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Furedan FDA foglio

    Furedan DMS (foglio di materiale di sicurezza)

    Furedan MSDS

    Furedan Sintesi di riferimento

    Nessuna informazione disponibile

    Furedan Peso molecolare

    238.157 g/mol

    Furedan Temperatura di fusione

    263 oC

    Furedan H2O Solubilita

    79,5 mg / L

    Furedan Stato

    Solid

    Furedan LogP

    -0.04

    Furedan Forme di dosaggio

    Compressa

    Furedan Indicazione

    Per il trattamento delle infezioni del tratto urinario

    Furedan Farmacologia

    Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.

    Furedan Assorbimento

    Nessuna informazione disponibile

    Furedan Tossicita

    Nessuna informazione disponibile

    Furedan Informazioni paziente

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Furedan Atto interessato organismi

    Gram negativi e alcuni batteri gram-positivi